HomeCompareOBTX vs MRK

OBTX vs MRK: Dividend Comparison 2026

OBTX yields 51.02% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OBTX wins by $357.5K in total portfolio value
10 years
OBTX
OBTX
● Live price
51.02%
Share price
$3.92
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$415.3K
Annual income
$85,519.64
Full OBTX calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — OBTX vs MRK

📍 OBTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOBTXMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OBTX + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OBTX pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OBTX
Annual income on $10K today (after 15% tax)
$4,336.73/yr
After 10yr DRIP, annual income (after tax)
$72,691.69/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, OBTX beats the other by $64,094.98/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OBTX + MRK for your $10,000?

OBTX: 50%MRK: 50%
100% MRK50/50100% OBTX
Portfolio after 10yr
$236.5K
Annual income
$47,816.71/yr
Blended yield
20.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

OBTX
No analyst data
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OBTX buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOBTXMRK
Forward yield51.02%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$415.3K$57.7K
Annual income after 10y$85,519.64$10,113.78
Total dividends collected$332.9K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OBTX vs MRK ($10,000, DRIP)

YearOBTX PortfolioOBTX Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$15,802$5,102.04$11,213$373.04+$4.6KOBTX
2$24,443$7,534.83$12,667$512.06+$11.8KOBTX
3$37,047$10,892.59$14,439$708.14+$22.6KOBTX
4$55,069$15,429.12$16,640$988.16+$38.4KOBTX
5$80,358$21,434.63$19,432$1,394.07+$60.9KOBTX
6$115,215$29,231.87$23,057$1,992.90+$92.2KOBTX
7$162,450$39,169.84$27,889$2,894.79+$134.6KOBTX
8$225,437$51,615.25$34,518$4,286.29+$190.9KOBTX
9$308,160$66,942.06$43,912$6,494.35+$264.2KOBTX
10$415,251$85,519.64$57,714$10,113.78+$357.5KOBTX

OBTX vs MRK: Complete Analysis 2026

OBTXStock

Everything Blockchain, Inc. engages in consulting and developing blockchain, and cybersecurity related solutions. The company offers EB Control, a zero trust data access solution for individuals and organizations; EB Advise, and EB Build. Everything Blockchain, Inc. was formerly known as ObitX, Inc. and changed its name to Everything Blockchain, Inc. in May 2021. The company was incorporated in 2017 and is headquartered in Jacksonville, Florida.

Full OBTX Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this OBTX vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OBTX vs SCHDOBTX vs JEPIOBTX vs OOBTX vs KOOBTX vs MAINOBTX vs JNJOBTX vs ABBVOBTX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.